Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Antimicrobial Agents and Chemotherapy|August 30, 2005
High-throughput human immunodeficiency virus type 1 (HIV-1) full replication assay that includes HIV-1 Vif as an antiviral targetJoan Cao, Jason Isaacson, Amy K Patick, et al.The Spine Journal : Official Journal of the North American Spine Society|March 7, 2006
Changes in spinal cord injury-induced gene expression in rat are strain-dependentCaroline Schmitt, Gurwattan S Miranpuri, Vinay K Dhodda, et al.Neuroreport|April 10, 2004
Molecular evidence of repair and plasticity following spinal cord injuryDaniel K Resnick, Caroline Schmitt, Gurwattan S Miranpuri, et al.Antiviral Research|February 15, 2005
A novel HIV-1 antiviral high throughput screening approach for the discovery of HIV-1 inhibitorsWade S Blair, Jason Isaacson, Xinqiang Li, et al.Bioorganic & Medicinal Chemistry Letters|November 12, 2017
PSMA-targeted bispecific Fab conjugates that engage T cellsJames T Patterson, Jason Isaacson, Lisa Kerwin, et al.Antimicrobial Agents and Chemotherapy|July 25, 2007
Identification and characterization of UK-201844, a novel inhibitor that interferes with human immunodeficiency virus type 1 gp160 processingWade S Blair, Joan Cao, Lynn Jackson, et al.Antimicrobial Agents and Chemotherapy|October 7, 2009
New small-molecule inhibitor class targeting human immunodeficiency virus type 1 virion maturationWade S Blair, Joan Cao, Juin Fok-Seang, et al.Plos Pathogens|December 21, 2010
HIV capsid is a tractable target for small molecule therapeutic interventionWade S Blair, Chris Pickford, Stephen L Irving, et al.Science Signaling|November 13, 2014
Resistance to dual blockade of the kinases PI3K and mTOR in KRAS-mutant colorectal cancer models results in combined sensitivity to inhibition of the receptor tyrosine kinase EGFRPeter J Belmont, Ping Jiang, Trevor D McKee, et al.Pageof 1